| Age, y, mean±SD |
68±13 |
77±13 |
0.003 |
| Female |
13 (33%) |
18 (45%) |
0.359 |
| Past medical history, n |
| Hypertension |
28 (72%) |
25 (63%) |
0.474 |
| Atrial fibrillation |
4 (10%) |
9 (23%) |
0.225 |
| Coronary artery disease |
5 (13%) |
11 (28%) |
0.161 |
| Diabetes mellitus |
10 (26%) |
6 (15%) |
0.274 |
| Hyperlipidemia |
11 (28%) |
8 (20%) |
0.439 |
| Dementia |
0 (0%) |
3 (8%) |
0.241 |
| Clinical variables |
| Glucose, mg/dL |
140.8±56.8 |
130.9±34.0 |
0.806 |
| Systolic blood pressure, mm Hg |
159.0±28.1 |
156.3±27.6 |
0.617 |
| Diastolic blood pressure, mm Hg |
82.3±21.5 |
83.1 ±20.8 |
0.830 |
| Platelet count, 1000/μL |
250.6±78.0 |
243.4±95.2 |
0.593 |
| Partial thromboplastin time, sec |
26.1 ±3.2 |
27.3±4.2 |
0.405 |
| International Normalized Ratio |
1.2±0.5 |
1.4±0.6 |
0.051 |
| Medications, n |
| Use of antiplatelet agents on admission |
9 (23%) |
12 (30%) |
0.612 |
| Use of warfarin on admission |
4 (10%) |
8 (20%) |
0.348 |
| Use of statin |
11 (28%) |
7 (18%) |
0.293 |
| Radiologic data |
| Time to MRI, h |
39.2±24.8 |
36.0±20.0 |
0.967 |
| Lobar ICH, n |
20 (51%) |
27 (68%) |
0.173 |
| ICH volume, mL |
17.4±20.8 |
36.0±45.2 |
0.022 |
| PHE volume, mL |
19.6±17.9 |
26.2±18.7 |
0.114 |
| Relative PHE |
1.60±0.86 |
1.25±0.80 |
0.05 |
| Presence of intraventricular hemorrhage, n |
6 (15%) |
4 (10%) |
0.518 |
| Presence of microbleed, n |
3 (8%) |
11 (28%) |
0.037 |
| No. of microbleeds |
| Total (both hemispheres) |
2.1 ±7.5 |
5.2±10.8 |
0.042 |
| Ipsilateral to ICH hemisphere |
1.3±4.3 |
2.7±5.2 |
0.024 |
| Discharge destination |
| Home |
17 (44%) |
9 (23%) |
0.058 |
| Extended-care facilities |
22 (56%) |
28 (70%) |
0.248 |
| Died during hospitalization |
0 |
3 (8%) |
0.241 |
